GSTP1, GSTM1, and GSTT1 genetic polymorphisms in patients with cryptogenic liver cirrhosis

详细信息    查看全文

• 作者：Shahrokh Mohammadzadeh Ghobadloo M.Sc. (1)
  Bahram Yaghmaei Ph.D. (1)
  Valery Bakayev Ph.D. (2)
  Hossein Goudarzi M.D. ; Ph.D. (1)
  Babak Noorinayer M.D. (2)
  Farhad Haghighi Rad M.Sc. (2)
  Saeed Samiy M.D. (2)
  Sohrab Aghabozorghi M.Sc. (2)
  Mohammad Reza Zali M.D. (2)
  
• 关键词：Glutathione S ; transferase genotype ; cryptogenic cirrhosis
• 刊名：Journal of Gastrointestinal Surgery
• 出版年：2004
• 出版时间：August 2004
• 年：2004
• 卷：8
• 期：4
• 页码：423-427
• 全文大小：131KB
• 参考文献：1. Oh S, Afdhal NH. Hepatic fibrosis: Are any of the serum markers useful? Curr Gastroenterol Rep 2001;3:12鈥?8. CrossRef
  2. Bataller R, North KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: A critical appraisal. Hepatology 2003;37:493鈥?03. CrossRef
  3. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease. Hepatology 1999;29:664鈥?69. CrossRef
  4. Cabre M, Camps J, Paternain JL, Ferre N, Joven J. Timecourse of changes in hepatic lipid peroxidation and glutathione metabolism in rats with carbon tetrachloride-induced cirrhosis. Hepatology 1999;29:664鈥?69. CrossRef
  5. Whalen R, Boyer TD. Human glutathione S-transferases. Semin Liver Dis 1998;18:345鈥?58.
  6. Strange RC, Spiteri MA, Ramachandran S, Fryer AA. Glutathione-S-transferase family of enzymes. Mutat Res 2001;482:21鈥?6.
  7. Sgambato A, Campisi B, Zupa A, Bochicchio A, Romano G, Tartarone A, Galasso R, Traficante A, Cittadini A. Glutathione S-transferase (GST) polymorphisms as risk factors for cancer in a highly homogeneous population from southern Italy. Anticancer Res 2002;22:3647鈥?652.
  8. Sheweita SA, Tilmisany AK. Cancer and phase II drug-metabolizing enzymes. Curr Drug Metab 2003;4:45鈥?8. CrossRef
  9. Frenzer A, Butler WJ, Norton ID, Wilson JS, Apte MV, Pirola RC, Ryan P, Roberts-Thomson IC. Polymorphism in alcohol-metabolizing enzymes, glutathione S-transferases and apolipoprotein E and susceptibility to alcohol-induced cirrhosis and chronic pancreatitis. J Gastroenterol Hepatol 2002; 17:177鈥?82. CrossRef
  10. Rodrigo L, Alvarez V, Rodriguez M, Perez R, Alvarez R, Coto E. N-acetyltransferase-2, glutathione S-transferase M1, alcohol dehydrogenase, and cytochrome P450IIE1 genotypes in alcoholic liver cirrhosis: a case-control study. Scand J Gastroenterol 1999;34:303鈥?07. CrossRef
  11. Davies MH, Elias E, Acharya S, Cotton W, Faulder GC, Fryer AA, Strange RC. GSTM1 null polymorphism at the glutathione S-transferase M1 locus: Phenotype and genotype studies in patients with primary biliary cirrhosis. Gut 1993;34:549鈥?53.
  12. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nulceic Acids Res 1988;16:1215. CrossRef
  13. Strange RC, Lear JT, Fryer AA. Glutathione S-transferase polymorphisms: Influence on susceptibility to cancer. Chem Biol Interact 1998;111:351鈥?64. CrossRef
  14. Roy B, Chowdhury A, Kundu S, Santra A, Dey B, Chakra- borty M, Majumder PP. Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 鈥榥ull鈥?mutation. J Gastroenterol Hepatol 2001;16:1033鈥?037. CrossRef
  15. Sun CA, Wang LY, Chen CJ, Lu SN, You SL, Wang LW, Wang Q, Wu DM, Santella RM. Genetic polymorphisms of glutathione S-transferases M1 and T1 associated with susceptibility to 14-aflatoxin-related hepatocarcinogenesis among chronic hepatitis B carriers: A nested case-control study in Taiwan. Carcinogenesis 2001;22:1289鈥?294. CrossRef
  16. Harada S. Investigation of the genetic markers associated with alcoholic liver diseases. Alcohol 1994;29(Suppl 1):33鈥?7.
  17. Henrion-Caude A, Flamant C, Roussey M, Housset C, Fla- hault A, Fryer AA, Chadelat K, Strange RC, Clement A. Liver disease in pediatric patients with cystic fibrosis is associated with glutathione S-transferase P1 polymorphism. Hepatology 2002;36:913鈥?17.
  18. Sokol RJ. Antioxidant defenses in metal-induced liver damage. Semin Liver Dis 1996;6:39鈥?6. CrossRef
  19. Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 2001;21:27鈥?1. CrossRef
  20. Yang Y, Cheng JZ, Singhal SS, Saini M, Pandya U, Awas- thi S, Awasthi YC. Role of glutathione S-transferases in protection against lipid peroxidation. Overexpression of hGSTA2-2 in K562 cells protects against hydrogen peroxide-induced apoptosis and inhibits JNK and caspase 3 activation. J Biol Chem 2001;276:19220鈥?9230. CrossRef
  21. Rao AV, Shaha C. Role of glutathione S-transferases in oxidative stress-induced male germ cell apoptosis. Free Radic Biol Med 2000;29:1015鈥?027. CrossRef
  22. Aceto A, Sacchetta P, Bucciarelli T, Dragani B, Angelucci S, Radatti GL, Di Ilio C. Structural and functional properties of the 34-kDa fragment produced by the N-terminal chymotryptic cleavage of glutathione transferase P1-1. Arch Biochem Biophys 1995;316:873鈥?78. CrossRef
  23. Elsby R, Kitteringham NR, Goldring CE, Lovatt CA, Cham- berlain M, Henderson CJ, Wolf CR, Park BK. Increased constitutive c-Jun N-terminal kinase signaling in mice lacking glutathione S-transferase Pi. J Biol Chem 2003;278:2243鈥?249. CrossRef
  24. Vontas JG, Small GJ, Hemingway J. Glutathione S-transferases as antioxidant defence agents confer pyrethroid resistance in Nilaparvata lugens. Biochem J 2001;357:65鈥?2. CrossRef
  25. Ruscoe JE, Rosario LA, Wang T, Gate L, Arifoglu P, Wolf CR, Henderson CJ, Ronai Z, Tew KD. Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways. J Pharmacol Exp Ther 2001;298:339鈥?45.
  
• 作者单位：Shahrokh Mohammadzadeh Ghobadloo M.Sc. (1)
  Bahram Yaghmaei Ph.D. (1)
  Valery Bakayev Ph.D. (2)
  Hossein Goudarzi M.D., Ph.D. (1)
  Babak Noorinayer M.D. (2)
  Farhad Haghighi Rad M.Sc. (2)
  Saeed Samiy M.D. (2)
  Sohrab Aghabozorghi M.Sc. (2)
  Mohammad Reza Zali M.D. (2)
  
  1. Department of Biochemistry and Genetics, Faculty of Medicine, Shaheed Beheshti University of Medical Sciences, P.O. Box 19395-4719, Evin, Tehran, Iran
  2. Research Center of Gastroenterology and Liver Disease, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  

文摘

We investigated glutathione S-transferase (GST) P1I le (105) Val, T1, and M1 polymorphisms in 45 patients with documented cryptogenic cirrhosis and 56 healthy control subjects. Polymerase chain reaction-based procedures were performed in the studied populations to confirm the genotypes of GSTT1, M1, and P1. Ile/Val and Val/Val GSTP1 genotypes were more frequent in the patients with cirrhosis (n = 39, 87%) than in the control subjects (n = 10; 18%) (odds ratio [OR] 34.04; 95% confidence interval [CI] 10.70 to 108.31, P < 0.001). Among these patients with cirrhosis, 16 were heterozygous and 23 were homozygous, whereas only one person in the control group was homozygous. The GSTM1 null genotype was also more prevalent in cirrhotic patients than in healthy control subjects (OR 6.83, 95% CI 2.53 to 18.42, P < 0.001). The rate of GSTT1 deletion did not show a significant difference between the two groups (OR 2.35, 95% CI 0.76 to 7.28, P = 0.111). To our knowledge, this is the first evidence that GSTP1 and GSTM1 polymorphisms may be related to the development of cirrhosis by unknown mechanisms. The significant association of cryptogenic cirrhosis with Val/Val GSTP1 genotype encoding a low detoxification activity protein implicates this polymorphism as a risk factor for the occurrence of the disease.